Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
June 28 2021 - 7:14AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
SOL-GEL TECHNOLOGIES LTD.
(Translation of registrant’s name into English)
For the month of May 2021
7 Golda Meir Street
Ness Ziona 7403650, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On May 13, 2021, Sol-Gel Technologies Ltd. (the “Company”) issued two press releases: (i) a press release announcing exclusive licenses with Galderma for the commercialization of EPSOLAY® and
TWYNEO® in the United States and (ii) a press release announcing the Company’s pipeline update and future development plans.
Attached hereto are the following exhibits:
This 6-K and Exhibits 99.1 and 99.2 are hereby incorporated by reference into the Company's Registration Statement on Form S-8 (Registration No. 333-223915) and its Registration Statement on Form
F-3 (Registration No. 333-230564).
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
SOL-GEL TECHNOLOGIES LTD.
|
|
|
|
|
|
|
Date: June 28, 2021
|
By:
|
/s/ Gilad Mamok
|
|
|
|
|
Gilad Mamlok
|
|
|
|
|
Chief Financial Officer
|
|
3
Sol Gel Technologies (NASDAQ:SLGL)
Historical Stock Chart
From Dec 2024 to Jan 2025
Sol Gel Technologies (NASDAQ:SLGL)
Historical Stock Chart
From Jan 2024 to Jan 2025
